Latest Intervacc News & Updates

See the latest news and media coverage for Intervacc. We track all announcements, press releases, and industry mentions in real time, all in one place.

Intervacc

Swedish animal health vaccine developer

intervacc.se

Headquarters: Stockholm, Sweden
Company type: Public company
Number of employees: 15–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Intervacc

In short: Intervacc expanded the global reach of its horse vaccine Strangvac, advanced its US market entry, and experienced a leadership transition.

Company announcements

July 30 Intervacc

Intervacc applies for 12 months immunity for Strangvac

The application is a type II variation to the EMA, supported by data showing protective antibody levels persist for 12 months.

July 29 Intervacc

Intervacc exports Strangvac to New Zealand after special import approval

The approval follows a request from NZEHA after a strangles outbreak. Initial delivery of 1,200 doses. Intervacc intends to apply for formal approval.

May 22 Intervacc

Intervacc has evaluated American strep bacteria strain ahead of clinical studies

The evaluation shows that the strain is identical to the European strain, enabling cost savings and time efficiencies ahead of US launch of Strangvac.

May 13 Intervacc

Intervacc publishes interim report for the first quarter of 2026

Net sales decreased and operating profit deteriorated.

Media coverage

July 29 FinanzNachrichten.de

Intervacc AB: Intervacc submits Type II variation to EMA seeking 12-month duration of immunity for Strangvac

Intervacc AB (publ) today announces that it has submitted a Type II variation application to the European Medicines Agency (EMA) for Strangvac, the company's innovative...

May 13 Yahoo Finance

Intervacc AB (OSTO:IVACC) Q1 2026: Everything You Need to Know Ahead of Earnings

This article first appeared on GuruFocus. Intervacc AB (OSTO:IVACC) is set to release its Q1 2026 earnings on May 13, 2026. The consensus estimate for...

April 16 FinanzNachrichten.de

Intervacc AB: Unprecedented decision opens the way for the launch of Strangvac in Iceland

Intervacc AB (publ) announces that Strangvac, the company's innovative vaccine against strangles in horses, has been approved by the authorities in Iceland. Strangles, a potentially...

March 19 FinanzNachrichten.de

Intervacc AB: Intervacc announces breakthrough protection against Streptococcus suis infection in piglets

Intervacc AB (publ) is first in the world to show that piglets were protected against the virulent and severe disease-causing S. suis Sequence Types 1...

Never miss news about Intervacc

Track Intervacc and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Intervacc competitors & trending companies

Browse news for competitors to Intervacc and other trending companies.